48
Alzheimer's disease (AD) and Aβ oligomers are collectively considered an appealing 49 therapeutic target for the treatment of AD. However, the molecular mechanisms leading to 50 the pathological accumulation of oligomers are unclear and the exact structural composition 51 of oligomers is being debated. Using targeted and quantitative mass spectrometry, we reveal 52 site-specific Aβ autocleavage during the early phase of aggregation, producing a typical Aβ 53 fragment signature and that truncated Aβ peptides can form stable oligomeric complexes with 54 full-length Aβ peptide. We show that the use of novel anti-Aβ antibodies raised against these 55 truncated Aβ isoforms allows for monitoring and targeting the accumulation of truncated Aβ 56 fragments. Antibody-enabled screening of transgenic models of AD, as well as human post-57 mortem brain tissue and cerebrospinal fluid revealed that, aggregation-associated Aβ 58 cleavage is a highly relevant clinical feature of AD. 59 Previously, mass spectrometry (MS) based analysis of CSF revealed a specific Aβ peptide 81 fragment signature in sporadic AD patients [14] [15] [16] and it has been reported that truncated Aβ 82 is known to represent more than 60% of all Aβ species found in non-demented as well as in 83 AD individuals [17] . These findings may suggest that Aβ oligomers could consist of a 84 heterogeneous morphological entity of full-length Aβ40 and Aβ42 as well as truncated AβWaltham, MA, USA). The instrument was operated in an information-dependent mode where 161 peptide masses for light and heavy lysine (K) labelled fragments Aβ16-23, Aβ16-24-NH2, 162
Aβ16-25 and Aβ16-27 (purchased from Sigma Aldrich, Germany) were selected for 163 collision-induced dissociation (CID) to generate tandem mass spectra using a normalized 164 collision energy (CE) of 35. Samples were first captured on a homemade capillary pre-165 column (Magic C18; 3 μm-200Å; 2 cm × 100 μm) prior to analytical separation. A 80-min 166 biphasic gradient was run starting from 100% A solvent (2% acetonitrile, 0.1% formic acid) 167 to 90% B solvent (100% acetonitrile, 0.1% formic acid) on capillary column (Nikkyo C18; 3 168 μm-100 Å; 15 cm × 75μm inner diameter at 250 nl/min). 169 2.6 Quantitation of Aβ peptide fragments using Selected Reaction Monitoring (SRM) 170 mass spectrometry. 171
All samples were analysed on a TSQ-Vantage triple quadrupole mass spectrometer 172 (Thermo Fisher Scientific). A 0.7-FWHM-resolution window for both Q1 and Q3 was set for 173 parent-and product-ion isolation. Fragmentation of parent ions was performed in Q2 at 1.5 174 mTorr, using collision energies calculated with the Pinpoint software (v1.1). Cycle times of 175 0.5s-1s were used for SRM runs with a minimum dwell time of 20ms. 176 Parent-ion selection was set for Lys-N digested peptides on the positively-charged parent 177
ions. CID fragmentation energies and the best transition selection were tested manually by 178 infusion on the TSQ using the synthetic peptide standards listed below. Mouse or humanbrain and CSF samples were extracted and prepared for digestion as outlined below. 180
Following overnight digestion at 37°C, samples were dried using a speed vacuum and stored 181 at −20°C until analyses were performed. For Aβ peptide quantitation studies, a mixture of 182 accurately quantified (by amino acid analysis) heavy isotope (lysine, K) labelled peptide 183 standards (Sigma Aldrich, Germany) comprising of residues: Aβ16-23, Aβ16-25, Aβ16-27, 184
Aβ28-38, Aβ28-40, Aβ28-42 and Aβ28-43, were spiked into each tube after resuspension of 185 samples in the Lys-N digestion buffer. Aβ peptide fragments were initially resuspended in a 186 solution containing 20% DMSO & 10% formic acid (FA) and further diluted to 5% DMSO & 187 2.5% FA prior to injection and analysis by LC-SRM. This solution provided maximum long-188 term stability of all peptide standards. Nano-LC-SRM parameters: Dried peptide aliquots 189 were resuspended in 20μl DMSO (10%) with 5% FA. This preparation provided peptide 190 solubility over two weeks without any significant changes in overall peptide recovery. 191
Following resuspension, samples were briefly sonicated (3min) and allowed to settle for 1h to 192 increase overall peptide solubility before analysis. Typically, 5μl of sample was loaded and 193 captured on a homemade capillary precolumn (C18; 3 μm, 200 Å; 2 cm × 250 μm) before 194 analytical LC separation (ACQUITY UPLC, Waters). Samples were separated using a 60min 195 biphasic gradient starting from 100% solvent A (100% acetonitrile, 0.1% formic acid) to 90% 196 solvent B (100% acetonitrile, 0.1% formic acid) on a Nikkyo (Nikkyo Technology) nano-197 column (C18; 3 μm, 100 Å; 150mm length and 100μm inner diameter; flow of 0.5μl/min). 198
The gradient was followed by a wash for 8 min at 90% solvent B and column re-equilibration 199 for 15 min at 100%. Briefly, a hepta to deca peptide sequence corresponding to the target neo-epitope 237 sequence of human Aβ peptide was conjugated to a KLH-linker and used for immunization 238 of rabbits (e.g. Aβ1-25: C+GG-VFFAEDVG-COOH). Antibodies (Table 1) Switzerland) using a Teflon homogenizer. Samples were then subjected to centrifugation 270 (150,000g) during 45min and the supernatant was recovered as the TBS soluble fraction. 271
Protein pellets were subjected to an additional extraction using either SDS (2%) or FA (70%) 272 followed by centrifugation. Typically, pellets were extracted with FA overnight at 4°C (to 273 minimize formylation adducts) followed by centrifugation. SDS fractions were diluted to≤0.1% SDS final concentration and FA fractions were neutralized to pH 7.5 with 5M sodium 275 hydroxide (NaOH) solution prior to IP. All samples were initially depleted of endogenous 276
IgG's using a mixture of protein A&G agarose beads (Roche AG, Switzerland). Typically, 2-277 4ug/ml rabbit polyclonal antibody (N-3s, N-4 or N-5ns) or 3-5ug/ml of 6E10 or 4G8 mouse 278 Interestingly, Aβ1-24 was found to be predominantly amidated (Aβ1-24-NH2) and only 329 minor levels of the normal carboxy C-terminus were detected (data not shown). Overall, we 330 observed that the gradual accumulation of the Aβ fragments of residues Aβ1-23, Aβ1-24-331 NH2, Aβ1-25 or Aβ1-25-NH2 reflect a typical fragment signature during the early phase of 332 peptide aggregation because these large N-terminal fragments could be readily detected 333 following short term aggregation (≤1h) and typically preceded the accumulation of earlier 334
reported Aβ isoforms such as Aβ1-15 (Supplemental Fig.1 ). We also observed that some N-335 terminal fragments have increased aggregation propensities, as seen by the rapid formation of 336 MS stable entities of dimeric and trimeric nature (Supplemental Fig.1 A&B) and that this in 337 turn may affect LC-MS analysis. Therefore, to monitor the generation of these Aβ isoforms 338 in a more reproducible manner, we processed samples using Lys-N proteolysis, which 339 generates the proteolytic cleavage product of residues Aβ16-25 [20] . Lys-N digestion of Aβ 340 peptides resulted in highly increased solution stabilities and MS detection (100 fold) of the 341 proteolytic cleavage products as compared to non-digested Aβ1-25 (Supplemental Fig. 1D ). 342
The change in overall charge distribution from multiply charged ions ([M+2H] 2+ to 343
5+ ) for Aβ1-25 to a predominantly double charged ion ([M+2H] 2+ ) for the Lys-N 344 fragment Aβ16-25 would generally account for this significantly improved detection. 345
Quantitative MS analysis, using a spiked-in heavy lysine (K16) labelled surrogate peptide 346 indicated, that the relative abundance of fragment Aβ1-25 accounts for approximately 5% of 347 full-length Aβ42 (Fig. 1D) . However, the absolute abundance of the here identified truncated (LMW) species in the range of 6kDa to 14kDa ( Fig. 2A) . High molecular weight (HMW) 363 oligomers were observed in the 49kDa to 62kDa range and this oligomeric entity was found 364 to be particularly characteristic for the amidated fragment Aβ1-25-NH2. Immunoblot analysis 365 of some Aβ isoforms remains challenging using the conventional antibody 6E10, as seen for 366
Aβ1-23, which may result from conformation associated epitope masking [21] , and therefore 367 a decreased sensitivity for 6E10 when compared with 4G8. 368 MS detection of LMW oligomers was mainly achieved at the dimer and trimer level, such 369 as shown with Aβ1-25, which may highlight the metastable structure found with soluble 370 oligomers during LC-MS analysis ( Supplementary Fig. 1A & B) . Moreover, prolonged aging 371 of the truncated Aβ isoforms Aβ1-25 or Aβ1-25-NH2 resulted in the generation of shorter N-372 terminal fragments such as the earlier reported fragments of residues Aβ1-14 and Aβ1-15( Supplementary Fig. 1C & E) . This observation was in agreement with prolonged Aβ42 374 aggregation experiments (t=7d), showing a time dependent decrease in MS detection of Aβ1-375 25 together with the gradual appearance of shorter fragments, such as Aβ1-15 376 (Supplementary Fig. 2A) . 377
Transmission electron microscopy (TEM) imaging indicated that N-terminal fragments 378 have a high propensity to form soluble, oligomeric aggregates following long-term 379 incubation. Aβ1-25 preferentially formed homogenous spherical aggregates, which was less 380 evident with the shorter N-terminal fragments of residues Aβ1-23 and Aβ1-24-NH2 and only 381 very few clusters of fibrils were observed with the amidated form Aβ1-25-NH2 ( Fig. 2A and  382 Supplemental Fig. 2F ). We further employed SEC (in Tris-NaCl) of aggregated Aβ1-25 and 383
show that the LMW structures typically observed with these truncated Aβ isoforms are true 384 observations and can therefore exclude a SDS-PAGE induced migration artefact (Fig. 2B) . 385 SEC fractionation resulted in a clear separation of two Aβ structures centered at the migration 386 level of ≤ 6kDa (fraction: 12ml) and ≤ 3kDa (fraction: 15ml) and MS analysis of fraction 387 volume 12ml revealed the presence of stable Aβ1-25 dimers and trimers, whereas monomers 388 were mainly detected in fraction volume 15ml (data not shown). Because Aβ1-25 dimers 389 (5.8kDa) and trimers (8.7kDa) were highly enriched in SEC fractions corresponding to a MW 390 standard of ≤14kDa, we speculated that LMW Aβ1-25 structures of may form part of larger 391
Aβ entities, which dissociate during SDS-PAGE analysis. 392 3.3 Monitoring Aβ peptide aggregation using neo-epitope antibodies which specifically 398 target truncated Aβ isoforms. 399
To create a simple analytical tool for the detection of site specific autocleavage during 400 aggregation we set out to develop an antibody enabled proof-of-principle tool for monitoringhigh binding specificity for N-terminal fragments of residues Aβ1-23 (N-3s), Aβ1-24-NH2 403 (N-4) and Aβ1-25 (N-5s & N-5ns) (Fig. 3 & Supplemental Fig 3A) , as well as for two 404 15 was significantly reduced with 6E10, which is an observation reported before [22] . 413 N-5s showed high specificity for the C-terminal Gly25 residue and N-3s selectively detected 414 fragments ending with C-terminal residue Asp23. The N-5ns binding epitope was found to 415 include residues spanning the neo-C-terminal region of residues 23-25, with preferential 416 binding properties for C-terminal Gly25 (Supplemental Fig. 3A ) and binding was 417 significantly decreased or absent with the shorter fragments of Aβ1-22 and Aβ1-15 418 respectively. Similarly, antibody N-4 revealed high binding specificity for the amidated C-419 teminal form of Val24 (Aβ1-24-NH2) (Fig. 3B) . Because of the analytical limitations 420 observed with DB (native conditions) we further compared the neo-epitope antibody 421 selectivity to 6E10 using immunoprecipitation (IP) of an Aβ fragment mixture along withextract) (Supplementary Fig. 4C & D) . All neo-epitope antibodies showed high selectivity for 424 their target fragments, whereas IP with 6E10 resulted in a pull-down of all Aβ fragments 425 together with full-length Aβ40. 426
The application of neo-epitope antibody N-5ns was further tested using ELISA and WB. At 427 working concentrations of ≤ 0.3ug/ml, N-5ns showed significantly lower affinity for the C-428 terminal amidated form Aβ1-25-NH2 (Fig. 3D) and WB revealed high selectivity for the 429 target fragments (Fig. 3E&F) . In summary we can conclude that, by using a combination of 430 different conventional techniques, we were able to show that the above mentioned neo- 
structure. 437
In order to understand the mechanisms associated with Aβ peptide cleavage during 438 aggregation we investigated peptide cleavage by stabilizing Aβ secondary structure in 439 different solutions. In PBS solution (or 40mM Tris: data not shown), Aβ40 showed a 440 predominantly unordered structure with considerable decrease in signal amplitude over the 441 time course of incubation, whereas incubation in 20% TFE solution induced a stable α-helical 442 structure during five days of incubation (Fig. 4A ). Significant Aβ cleavage was observed in 443 PBS or Tris solutions, whereas cleavage was strongly attenuated in TFE (Fig. 4 B & C) , 444
indicating that Aβ cleavage is highly associated with changes of the peptide's secondary 445 structure as a result of peptide aggregation. This observation was also true for Aβ42 (data not 446 shown).
Having established neo-epitope antibody specificity, we then selected and employed N-448 5ns to monitor in vitro Aβ42 aggregation using DB and MS. We observed a robust increase 449 in N-5ns DB signal shortly after peptide incubation indicating a nearly instantaneous 450 accumulation of diagnostic Aβ fragments and TEM imaging of the peptide morphology 451 indicated that there was a correlation between the N-5ns signal saturation by DB and the 452 presence of typical oligomeric and protofibrilar aggregates (Fig. 4D) . 453 We further studied the effects of different experimental conditions in Aβ aggregation. could be detected by DB (Fig. 4E) and IP-MS analysis confirmed the presence of the N-5ns 461 target fragments Aβ1-23 and Aβ1-25 in samples subjected to different aggregation conditions 462 (Fig. 4F) . 463
Since we were able to show that several peptide cleavage sites represent a typical hallmark 464 of early aggregation, we argued that the sum of several cleavage products would increase 465 overall DB screening sensitivity and showed, that the combination of several neo-epitope 466 antibodies indeed increased detection sensitivity during in vitro peptide aggregation 467 (Supplementary Fig. 4A ). We further reasoned that neo-epitope antibody-based monitoring of 468 Aβ species was subjected to SEC fractionation. To identify SEC fractions containing 485 truncated Aβ isoforms, 50ul fractions were dried by speed vacuum and re-suspended in 5ul of 486 PBS of which 1ul was spotted in duplicates onto a nitrocellulose membrane and probed by 487 DB using N-5ns and 6E10 respectively. SEC fraction probing with N-5ns allowed 488 identification of a substantial amount of truncated Aβ within the oligomeric fractions (8ml -489 12ml) (Fig.5A ). DB probing with 6E10 and N-5ns of the monomeric fraction (18ml) 490 indicated that this fraction contained a mixture of both, Aβ42 monomers as well as truncated 491
Aβ isoforms and WB analysis of these SEC fractions was in line with the findings from DB 492 (Fig. 5B) . Moreover, WB also revealed the presence of HMW oligomers centered at the 493 49kDa to 62kDa range. The presence of low amounts of this HMW entity observed in the 494 monomeric fraction may indicate that truncated Aβ fragments may favor the formation of 495 these HMW structures as a result of sample concentration by speed-vacuum.
confirmed the presence of different truncated Aβ isoforms as well as their complementary C-502 terminal fragments (Supplementary Fig.5 ). 503 IP with N-4 resulted in a specific pull-down of fragment Aβ1-24-NH2 ( Fig. 5C ; center) 504 along with Aβ42 and N-5ns allowed a specific recovery of fragments Aβ1-25 but not Aβ1-505 25-NH2, as well as trace amounts of Aβ1-23 together with Aβ42 ( Fig. 5C; bottom) . 506
To further elucidate the importance of Aβ1-25 in oligomers, we analyzed two oligomeric 507 (11.5ml and 14ml) and a monomeric fraction (18ml) using IP-MS (N-5ns) (Fig. 5D) and 508 could identify Aβ1-25 in both, oligomeric and monomeric fractions. The relative abundance 509 of this particular fragment varied considerably, which was in line with our DB and WB 510 analysis. IP with N-5ns also resulted in a pull-down of Aβ42 indicating that oligomeric, as 511 well as monomeric fractions contained metastable complexes of fragment Aβ1-25 and Aβ42, 512 which may dissociate to a generally monomeric level during SDS-PAGE analysis. This data 513 collectively confirms the above reported observation that truncated Aβ can form stable 514 entities with soluble oligomers. 515
To provide quantitative values for Aβ1-25 and Aβ42 we used IP combined with LC-SRM 516 analysis. SEC fractions were split and one part was denatured with 70% FA over-night at 4°C 517 to allow gradual dissociation of large oligomeric species. We reasoned that this approach 518 would reduce the overall recovery (pull-down) of full-length Aβ42 stably bound to the 519 surface of large oligomers and therefore allow more accurate quantitation of the Aβ1-25 520 target fragment per se. SRM quantitation confirmed the significantly lower levels of Aβ1-25(2-3pg/ul) (Fig. 5E ) found in fraction volume 11.5ml as compared to the monomeric (18ml) 522 fraction (21-23pg/ul), which is also in line with our WB analysis. Moreover, we found that 523 FA dissociation of oligomers significantly reduced (40x) the amount of full-length Aβ42 524 stably bound to fragment Aβ1-25. IP-MS of the monomeric fraction, using a combination of 525 three different neo-epitope antibodies, revealed the presence of three truncated isoforms: 526 Aβ1-23, Aβ1-24-NH2 and Aβ1-25 together with Aβ42 (Fig. 5F) . 527
Because our initial mock IP's of freshly prepared Aβ fragment mixtures did not pull-down 528 full-length Aβ40 or Aβ42, we sought to provide direct evidence that detection of Aβ42 within 529 the monomeric fraction is the result of a collective pull-down due to stable interaction of 530 truncated Aβ and Aβ42. For this purpose, we denatured the first IP sample over-night using 531 90% FA, followed by a second IP using the same antibody cocktail. MS analysis of the 532 sequential IP (2 nd ) confirmed our assumption, because Aβ42 was no longer detected 533 following FA treatment (Fig. 5G) . 534 MS analysis of the insoluble, pellet fraction (from ADDL prep.) indicated that large 535 insoluble aggregates also consist of heterogenic entities rich in N-terminal as well as C-536 terminal truncated Aβ isoforms together with full-length Aβ42 (data not shown). This 537 observation was further corroborated by the finding that IP with antibody N-5s or N-5ns of 538 7M guanidine hydrochloride (GHCl) denatured Aβ42 fibrils, resulted in a specific recovery 539 of Aβ1-25 together with trace amounts of Aβ42 ( Supplementary Fig. 6A & B) . Immunohistochemical staining (both chromogenic and fluorescent) of the frontal cortical 548 tissue of human sporadic AD subjects (N = 6 AD cases and 3 age-matched non-demented 549 controls) using N-5ns resulted in robust labeling of thioflavin-S-positive amyloid plaques and 550 cerebral amyloid angiopathy (CAA) (Fig. 6A & B) . Thioflavin-S-positive intraneuronal tau 551 tangles were not labelled with N-5ns (Fig. 6B) and no non-specific labeling was detected in 552 the control non-AD brains (Fig. 6C) . Because one of the early and important effects of 553 oligomeric Aβ in AD is the binding of Aβ to synapses and the resultant synaptic dysfunction 554 and loss [31], we examined the presence of Aβ neo-epitopes in synapses. Tissue from human 555 subjects was prepared for high-resolution array tomography [32], allowing accurate detection 556 of individual synapses. As seen with the immunostaining of paraffin sections, N-5ns labeled 557 amyloid deposits that were positive for thioflavin-S and 6E10 (Fig. 6D) . Both dense-core and 558 diffuse plaques were immuno-positive for N-5ns. We also observed staining of N-5ns at 559 individual pre-and postsynaptic puncta in the region of plaques, indicating that this Aβ 560 fragment may be important in synapse degeneration (Fig. 6E) . indicating that both AD samples contained truncated Aβ isoforms, whereas 4G8 failed to 576
show similar specificity at this migration level, which is an observation also made with the 577 synthetic Aβ fragments (Fig. 3) . 578
We further analyzed the same brain samples by MALDI-TOF/TOF MS. IP-MS (6E10&4G8) 579 analysis of the AD#2 brain tissue extract (FA) resulted in a pull-down of large Aβ fragments 580 Aβ36, Aβ37, Aβ38 and Aβ40 together with several N-terminal fragments Aβ1-13-NH2, Aβ1-581 13, Aβ1-20, Aβ1-22, Aβ1-23, Aβ2-24-NH2 Aβ1-24-NH2 and Aβ1-25 (Fig. 7B) . IP-MS 582 analysis of the same AD brain, using a combination of three neo-epitope antibodies resulted 583 in a specific pull-down of the target fragments (Fig. 7C) . The same samples were also 584 subjected to LC-MS/MS (Orbitrap) analysis for high resolution peptide mass confirmation 585 ( Fig. 7D & E) . 586
Moreover show that, IP with N-5ns enables a specific recovery of fragment Aβ1-25 from 587 Tg2576, APP/PS1 ( Supplementary Fig. 6C & D) and 5xFAD (data not shown) transgenic 588 mice brains. The use of SDS (Supplemental Fig. 7) , TBS or FA ( Supplementary Fig. 8A & B ) 589 extraction protocols all resulted in similar truncated Aβ recovery, however, the levels of Aβ1-590 25 were found to be significantly increased in FA extracts as compared to TBS soluble 591 fractions ( Supplementary Fig. 8B ). LC-SRM analysis of TBS and FA brain extracts from 592 human controls indicated that the levels of cleaved Aβ isoforms are significantly reduced or 593 below the limit of detection (data not shown). 594
Human CSF analysis reflects the accumulation of N-terminal fragments in AD 596

brain. 597
We first measured levels of Aβ42 and total Tau (T-Tau) in AD patients and non-demented 598 (ND) controls using ELISA and observed significantly (p<0.001) decreased levels of Aβ42 as 599 well as increased T-Tau levels (p<0.001) ( Supplementary Fig. 8C & D) in AD patients as 600 compared to ND controls, which is in line with earlier reported measurements of human CSF 601 samples [11, 33] . We were further interested in identifying Aβ cleave by applying 602 quantitative IP-SRM (N-5ns) to measure Aβ1-25 levels in CSF and could clearly confirm the 603 presence of Aβ1-25 in both; AD patients and age matched controls subjects (Supplementary 604 Fig. 8E) . A large inter-subject variability of Aβ1-25 levels was generally observed in AD 605 patients (n=16) but the measured levels failed to show a statistical significant difference 606 (p>0.05) when compared to control subjects (n=14) (Supplementary Table II [41] and that the increased aggregation observed for Aβ40 in the presence oftTGase was accompanied with significant cleavage at residues Glu22 and Gly25 respectively 621
[18]. Moreover, it has been suggested that Aβ25-35 as well as full-length Aβ40 mediated 622 toxicity may result from a peptide cleavage induced radicalisation of cell membranes, and 623 that prolonged incubation resulted in significant Aβ cleavage at the Gly25-Ser26 bond [42] . 624
The here reported occurrence of cleavage at residue Gly25 is of particular interest, because 625
Aβ1-25 was earlier identified as a sphingolipid binding domain motif, which can be rapidly 626 internalized by neuronal cells [43] . 627
We report here new, additional Aβ fragments and were able to demonstrate that the 628 gradual appearance of fragments Aβ1-23, Aβ1-24-NH2 Aβ1-25 and its amidated form Aβ1-629 25NH2 can be associated with the early events of Aβ aggregation, because MS detection of 630 the aforementioned N-terminal fragments precedes the accumulation of shorter Aβ isoforms 631 (i.e Aβ1-15). 632
To our knowledge, the presence of substantial C-terminal amidation in vitro and in vivo 633 has not been reported before, suggesting that Aβ cleavage is the result of at least two distinct 634 molecular mechanisms. More importantly, we show that Aβ cleavage is strongly attenuated 635 when stabilizing the peptide in an α-helical structure. This suggests that the transition from an 636 unstructured, random-coil conformation to a β-sheet ordered structure triggers the cleavage 637 cascade typically observed during peptide aggregation. Moreover, the time-dependent 638 increase in Aβ1-15 abundance may indicate that shorter N-terminal fragments represent 639 cleavage products associated with a more advanced phase of aggregation, which is 640 corroborated by the observation that long-term incubation of the here described fragment of 641 Aβ1-25, or its more amyloidogenic form Aβ1-25-NH2, give rise to shorter Aβ isoforms. 642
Generally, the detection of a particular Aβ fragment signature in different AD transgenic 643 models as well as human AD brains; collectively highlight the need for further understandingthe presence of Aβ fragment signatures in AD. Therefore, the exact molecular mechanism 645 leading to site specific hydrolysis of Aβ remains to be elucidated in future studies.
here that IP of soluble Aβ40 or Aβ42 oligomers resulted in a specific recovery of Aβ 649 assemblies with a gel migration range of ≥6kDa, and that similar Aβ assemblies could be 650 detected in TBS and FA lysates from human AD brains. Given by our findings, it is 651 conceivable that Aβ assemblies of putative dimeric or trimeric nature consist of a mixture of 652 truncated and full-length Aβ, which may form metastable complexes with HMW structures, 653 which is partly in agreement with earlier reports [19] . 654
The detection of Aβ1-25 in CSF samples from human controls may suggest a significant 655 abundance of Aβ oligomers present in control subjects, which is in line with earlier reports 656 [45] . Interestingly, Holtta et al. (2013) showed that CSF oligomers were significantly 657 increased in patients with mild and moderate dementia when compared to controls, whereas 658 no significant difference was found in patients with severe dementia [12] . The here observed 659 lack of statistical significance in Aβ1-25 levels in AD patients may result from the relatively 660 small sample size and hence statistical power. It is also conceivable that CSF sample freeze-661 thaw cycles together with other, earlier reported cofounding factors [46, 47] may have 662 collectively contributed to a rapid ex vivo Aβ aggregation in these samples. 663
In conclusion, we argue that neo-epitope antibodies would serve as appealing capture 664 antibodies for future ELISA developments because we were able to show that the here 665 described Aβ fragments can self-propagate to dimers and trimers or form stable entities with 666 large oligomers. However, measuring changes in levels of truncated Aβ isoforms merits 667 additional, future analytical improvements. We believe that monitoring pathological changes 668 in Aβ levels in human CSF [39] 
RESEARCH IN CONTEXT 675
Systematic Review: Aβ dimers, trimers and dodecamers have received the most scientific 676 attention in the past, because these entities have been suggested to form the building blocks of 677 larger neurotoxic assemblies. However, the key molecular triggers associated with early Aβ 678 oligomerization are poorly understood and to date, the exact molecular structure of LMW 679 oligomers still remains a conundrum. 680
Interpretation: We have identified here new truncated Aβ isoforms with high aggregation 681
propensities, which may serve as seeding units during early peptide aggregation. We provide 682 analytical evidence that these truncated Aβ isoforms are highly abundant in Aβ oligomers. 683
Future directions: We plan to further study the generation of truncated Aβ isoforms as 684 well as their significance to the pre-symptomatic accumulation of neurotoxic oligomers. The 685 use typical Aβ peptide fragment fingerprints for a pre-symptomatic diagnosis of subjects 686 suffering from MCI or other forms of dementia will be of particular interest. Furthermore, we 687 are interested in studying the structural properties and aggregation fate of the here described 688 truncated Aβ isoforms. This will help to identify and understand the structure homology 689 found in Aβ oligomers which in turn may improve the future development of oligomer 690 specific antibodies. 691
